HI
AVNS

HBK Investments’s Avanos Medical AVNS Stock Holding History

HBK Investments’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,600
Closed -$259K – 1008
2017
Q2 		$259K Buy
+6,600
New +$249K ﹤0.01% 837
2017
Q1 		– Sell
-15,600
Closed -$577K – 668
2016
Q4 		$577K Sell
15,600
-68,986
-82% -$2.47M 0.01% 539
2016
Q3 		$2.93M Buy
+84,586
New +$2.96M 0.03% 295

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HBK Investments's AVNS Position: Q3 2017 in Review

HBK Investments sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 6,600 shares — an estimated $259K sold.

HBK Investments first reported a position in AVNS in Q3 2016 and held it in 3 quarters. The position peaked at $2.93M in Q3 2016. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • HBK Investments reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • HBK Investments sold 6,600 Avanos Medical shares in Q3 2017, an estimated $259K.
  • HBK Investments first reported a position in Avanos Medical in Q3 2016 and held it in 3 quarters.
  • HBK Investments's Avanos Medical position peaked at $2.93M in Q3 2016.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on HBK Investments's 13F filing for Q3 2017, filed 14 Nov 2017.